Related by context. Frequent words. (Click for all words.) 72 Phase 1b clinical 72 Phase 1b 70 Phase 2a trial 70 randomized Phase III 70 Phase 1b trial 70 phase IIb 69 phase 2a 69 axitinib 69 HGS ETR1 69 Phase Ib 68 SCH # 68 relapsed refractory multiple myeloma 68 dose escalation trial 68 Phase 2a clinical 68 phase IIa 68 Phase 2b clinical 67 Phase 2b study 67 Phase 2a 67 pralatrexate 66 placebo controlled clinical 66 HER2 positive metastatic breast 66 nab paclitaxel 66 AACR NCI EORTC 66 rNAPc2 66 Phase IIa trial 65 dose cohorts 65 romidepsin 65 Phase IIa clinical 65 Clinical Trial Results 65 Phase 2b 64 confirmatory Phase 3 64 Clinical Oncology Annual Meeting 64 Phase IIb clinical 64 refractory multiple myeloma 64 AP# [003] 64 double blinded placebo 64 randomized Phase 64 label dose escalation 64 Genasense R oblimersen 64 nitazoxanide 64 sapacitabine 64 multicenter randomized double 64 CYT# 64 Phase 2b trial 64 MOZOBIL 64 relapsed multiple myeloma 64 Phase 1a 64 Phenoptin 64 TELCYTA 64 MGCD# [001] 64 Phase III randomized 63 active comparator 63 Phase III clinical 63 HCV protease inhibitor 63 Phase III pivotal 63 CoFactor 63 BAY #-# 63 eniluracil 63 GRN#L 63 Phase Ia 63 ZYBRESTAT 63 FavId 63 PS# [001] 63 pivotal Phase 63 Reolysin 63 CA4P 63 IMGN# 63 PXD# 63 Perifosine 63 PEG Interferon lambda 63 aflibercept 63 orally bioavailable 63 BCX# 62 Allovectin 7 R 62 MDV# 62 PF # [001] 62 multicenter randomized 62 pivotal Phase III 62 confirmatory Phase III 62 Phase IIb 62 INCB# [002] 62 thymalfasin 62 temsirolimus 62 metastatic renal cell carcinoma 62 administered subcutaneously 62 Bortezomib 62 sodium Injection 62 OXi# 62 neoadjuvant 62 Chronic Hepatitis C 62 seliciclib 62 ASCO Annual Meeting 62 decitabine 62 imetelstat 62 Phase IIa 62 multicenter clinical 61 Solid Tumors 61 RG# [001] 61 Taxotere ® 61 dose escalation 61 DB# [003]